Literature DB >> 23012427

NMDA receptor function in large-scale anticorrelated neural systems with implications for cognition and schizophrenia.

Alan Anticevic1, Mark Gancsos, John D Murray, Grega Repovs, Naomi R Driesen, Debra J Ennis, Mark J Niciu, Peter T Morgan, Toral S Surti, Michael H Bloch, Ramachandran Ramani, Mark A Smith, Xiao-Jing Wang, John H Krystal, Philip R Corlett.   

Abstract

Glutamatergic neurotransmission mediated by N-methyl-d-aspartate (NMDA) receptors is vital for the cortical computations underlying cognition and might be disrupted in severe neuropsychiatric illnesses such as schizophrenia. Studies on this topic have been limited to processes in local circuits; however, cognition involves large-scale brain systems with multiple interacting regions. A prominent feature of the human brain's global architecture is the anticorrelation of default-mode vs. task-positive systems. Here, we show that administration of an NMDA glutamate receptor antagonist, ketamine, disrupted the reciprocal relationship between these systems in terms of task-dependent activation and connectivity during performance of delayed working memory. Furthermore, the degree of this disruption predicted task performance and transiently evoked symptoms characteristic of schizophrenia. We offer a parsimonious hypothesis for this disruption via biophysically realistic computational modeling, namely cortical disinhibition. Together, the present findings establish links between glutamate's role in the organization of large-scale anticorrelated neural systems, cognition, and symptoms associated with schizophrenia in humans.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23012427      PMCID: PMC3478611          DOI: 10.1073/pnas.1208494109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  51 in total

Review 1.  NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development.

Authors:  John H Krystal; D Cyril D'Souza; Daniel Mathalon; Edward Perry; Aysenil Belger; Ralph Hoffman
Journal:  Psychopharmacology (Berl)       Date:  2003-09-02       Impact factor: 4.530

2.  Mg2+ imparts NMDA receptor subtype selectivity to the Alzheimer's drug memantine.

Authors:  Shawn E Kotermanski; Jon W Johnson
Journal:  J Neurosci       Date:  2009-03-04       Impact factor: 6.167

3.  Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats.

Authors:  B Moghaddam; B W Adams
Journal:  Science       Date:  1998-08-28       Impact factor: 47.728

4.  Toward discovery science of human brain function.

Authors:  Bharat B Biswal; Maarten Mennes; Xi-Nian Zuo; Suril Gohel; Clare Kelly; Steve M Smith; Christian F Beckmann; Jonathan S Adelstein; Randy L Buckner; Stan Colcombe; Anne-Marie Dogonowski; Monique Ernst; Damien Fair; Michelle Hampson; Matthew J Hoptman; James S Hyde; Vesa J Kiviniemi; Rolf Kötter; Shi-Jiang Li; Ching-Po Lin; Mark J Lowe; Clare Mackay; David J Madden; Kristoffer H Madsen; Daniel S Margulies; Helen S Mayberg; Katie McMahon; Christopher S Monk; Stewart H Mostofsky; Bonnie J Nagel; James J Pekar; Scott J Peltier; Steven E Petersen; Valentin Riedl; Serge A R B Rombouts; Bart Rypma; Bradley L Schlaggar; Sein Schmidt; Rachael D Seidler; Greg J Siegle; Christian Sorg; Gao-Jun Teng; Juha Veijola; Arno Villringer; Martin Walter; Lihong Wang; Xu-Chu Weng; Susan Whitfield-Gabrieli; Peter Williamson; Christian Windischberger; Yu-Feng Zang; Hong-Ying Zhang; F Xavier Castellanos; Michael P Milham
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-22       Impact factor: 11.205

5.  Brain network connectivity in individuals with schizophrenia and their siblings.

Authors:  Grega Repovs; John G Csernansky; Deanna M Barch
Journal:  Biol Psychiatry       Date:  2010-12-30       Impact factor: 13.382

6.  Impact of in-scanner head motion on multiple measures of functional connectivity: relevance for studies of neurodevelopment in youth.

Authors:  Theodore D Satterthwaite; Daniel H Wolf; James Loughead; Kosha Ruparel; Mark A Elliott; Hakon Hakonarson; Ruben C Gur; Raquel E Gur
Journal:  Neuroimage       Date:  2012-01-02       Impact factor: 6.556

7.  Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex.

Authors:  B Moghaddam; B Adams; A Verma; D Daly
Journal:  J Neurosci       Date:  1997-04-15       Impact factor: 6.167

Review 8.  Interneuron dysfunction in psychiatric disorders.

Authors:  Oscar Marín
Journal:  Nat Rev Neurosci       Date:  2012-01-18       Impact factor: 34.870

Review 9.  Serotonin-dopamine interaction and its relevance to schizophrenia.

Authors:  S Kapur; G Remington
Journal:  Am J Psychiatry       Date:  1996-04       Impact factor: 18.112

10.  Neocortical excitation/inhibition balance in information processing and social dysfunction.

Authors:  Ofer Yizhar; Lief E Fenno; Matthias Prigge; Franziska Schneider; Thomas J Davidson; Daniel J O'Shea; Vikaas S Sohal; Inbal Goshen; Joel Finkelstein; Jeanne T Paz; Katja Stehfest; Roman Fudim; Charu Ramakrishnan; John R Huguenard; Peter Hegemann; Karl Deisseroth
Journal:  Nature       Date:  2011-07-27       Impact factor: 49.962

View more
  120 in total

1.  In vivo ketamine-induced changes in [¹¹C]ABP688 binding to metabotropic glutamate receptor subtype 5.

Authors:  Christine DeLorenzo; Nicole DellaGioia; Michael Bloch; Gerard Sanacora; Nabeel Nabulsi; Chadi Abdallah; Jie Yang; Ruofeng Wen; J John Mann; John H Krystal; Ramin V Parsey; Richard E Carson; Irina Esterlis
Journal:  Biol Psychiatry       Date:  2014-07-10       Impact factor: 13.382

Review 2.  Glutamate-mediated excitotoxicity in schizophrenia: a review.

Authors:  Eric Plitman; Shinichiro Nakajima; Camilo de la Fuente-Sandoval; Philip Gerretsen; M Mallar Chakravarty; Jane Kobylianskii; Jun Ku Chung; Fernando Caravaggio; Yusuke Iwata; Gary Remington; Ariel Graff-Guerrero
Journal:  Eur Neuropsychopharmacol       Date:  2014-08-01       Impact factor: 4.600

3.  Memories reactivated under ketamine are subsequently stronger: A potential pre-clinical behavioral model of psychosis.

Authors:  Michael J Honsberger; Jane R Taylor; Philip R Corlett
Journal:  Schizophr Res       Date:  2015-02-24       Impact factor: 4.939

Review 4.  Glutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: ketamine and other compounds.

Authors:  Mark J Niciu; Ioline D Henter; David A Luckenbaugh; Carlos A Zarate; Dennis S Charney
Journal:  Annu Rev Pharmacol Toxicol       Date:  2014       Impact factor: 13.820

5.  Static and dynamic characteristics of cerebral blood flow during the resting state in schizophrenia.

Authors:  Jochen Kindler; Kay Jann; Philipp Homan; Martinus Hauf; Sebastian Walther; Werner Strik; Thomas Dierks; Daniela Hubl
Journal:  Schizophr Bull       Date:  2013-12-10       Impact factor: 9.306

Review 6.  Impaired Tuning of Neural Ensembles and the Pathophysiology of Schizophrenia: A Translational and Computational Neuroscience Perspective.

Authors:  John H Krystal; Alan Anticevic; Genevieve J Yang; George Dragoi; Naomi R Driesen; Xiao-Jing Wang; John D Murray
Journal:  Biol Psychiatry       Date:  2017-01-13       Impact factor: 13.382

7.  Identification of a Novel Rat NR2B Subunit Gene Promoter Region Variant and Its Association with Microwave-Induced Neuron Impairment.

Authors:  Li-Feng Wang; Da-Wei Tian; Hai-Juan Li; Ya-Bing Gao; Chang-Zhen Wang; Li Zhao; Hong-Yan Zuo; Ji Dong; Si-Mo Qiao; Yong Zou; Lu Xiong; Hong-Mei Zhou; Yue-Feng Yang; Rui-Yun Peng; Xiang-Jun Hu
Journal:  Mol Neurobiol       Date:  2015-04-28       Impact factor: 5.590

8.  Ketamine induced changes in regional cerebral blood flow, interregional connectivity patterns, and glutamate metabolism.

Authors:  James Edward Bryant; Michael Frölich; Steve Tran; Meredith Amanda Reid; Adrienne Carol Lahti; Nina Vanessa Kraguljac
Journal:  J Psychiatr Res       Date:  2019-07-27       Impact factor: 4.791

9.  Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor.

Authors:  Franz X Vollenweider; Alan Anticevic; Katrin H Preller; Joshua B Burt; Jie Lisa Ji; Charles H Schleifer; Brendan D Adkinson; Philipp Stämpfli; Erich Seifritz; Grega Repovs; John H Krystal; John D Murray
Journal:  Elife       Date:  2018-10-25       Impact factor: 8.140

10.  Regional excitation-inhibition balance predicts default-mode network deactivation via functional connectivity.

Authors:  Hong Gu; Yuzheng Hu; Xi Chen; Yong He; Yihong Yang
Journal:  Neuroimage       Date:  2018-10-22       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.